Peter Wutzler

Per aspera ad astra: application of Simplex QSAR approach in antiviral research.

Eugene N Muratov, Pavel G. Polischuk, Michaela Schmidtke, 2010, Future medicinal chemistry.

Method and apparatus for sterilizing or disinfecting of Objects

Peter Wutzler, Horst Muecke, Lauri Santasalo, 1988 .

QSAR Studies On [(Biphenyloxy)propyl]isoxazole Derivatives With Anti-rhinovirus 2 Activity

Anatoly G. Artemenko, Eugene N. Muratov, Victor E. Kuz’min, 2007 .

Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008

Michaela Schmidtke, Peter Wutzler, M. Schmidtke, 2011, Medical Microbiology and Immunology.

QSAR Analysis of Anti-Coxsackievirus B3 Nancy Activity of 2-Amino-3-Nitropyrazole[1,5-α]Pyrimidines by Means of Simplex Approach

Anatoly G. Artemenko, Eugene N. Muratov, Victor E. Kuz’min, 2007 .

Validation of health economic models: the example of EVITA.

Stefan Wagenpfeil, Peter Wutzler, S. Wagenpfeil, 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Swine Influenza A Vaccines, Pandemic (H1N1) 2009 Virus, and Cross-Reactivity

Andi Krumbholz, Peter Wutzler, S. Baumgarte, 2010, Emerging infectious diseases.

QSAR analysis of [(biphenyloxy)propyl]isoxazoles: agents against coxsackievirus B3.

Michaela Schmidtke, Peter Wutzler, E. Muratov, 2011, Future medicinal chemistry.

Poly(rC)-binding protein 2 interacts with the oligo(rC) tract of coxsackievirus B3.

Matthias Görlach, Peter Wutzler, R. Zell, 2008, Biochemical and biophysical research communications.

Hit QSAR Analysis of Anti-Coxsackievirus B3 Activity of [(Biphenyloxy)Propyl]Isoxazole Derivatives

Anatoly G. Artemenko, Eugene N. Muratov, Victor E. Kuz’min, 2008 .

QSAR Analysis of Cytotoxicity in HeLa Cells

Anatoly G. Artemenko, Eugene N. Muratov, Victor E. Kuz’min, 2008 .